000 03791cam a2200421Ii 4500
999 _c96166
_d96166
001 96166
003 ES-MaUEC
005 20230102112741.0
006 m o d
007 cr cnu|||unuuu
008 170614s2017 sz a ob 001 0 eng d
020 _a3319576968
_q(electronic bk.)
020 _a9783319576961
_q(electronic bk.)
020 _z331957695X
020 _z9783319576954
040 _aN$T
_cN$T
_dN$T
_dOCLCO
_dGW5XE
_dEBLCP
_dYDX
_dUAB
_dAZU
_dUPM
_dMERER
_dESU
_dOCLCQ
_dCOO
_dOCLCQ
_dIOG
_dES-MaUEC
_bspa
050 4 _aRS199.5
_bD784 2017 EB
245 0 0 _aDrug and gene delivery to the central nervous system for neuroprotection :
_bnanotechnological advances
_cHari S. Sharma, Dafin F. Muresanu, Aruna Sharma, editors.
264 1 _aCham
_bSpringer
_c2017.
300 _a1 recurso en línea
_bilustraciones (algunas a color)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
500 _aSpringerLink
504 _aIncluye referencias bibliográficas e índice
505 0 _aChapter 1 Renewable Biomaterials as Nanocarriers for Drug and Gene Delivery -- Chapter 2 Nanocarriers as CNS Drug Delivery Systems for Enhanced Neuroprotection -- Chapter 3 Nanotechnology Based Approaches for Neurodegenerative Disorders: Diagnosis and Treatment -- Chapter 4 Viral Vector Gene Delivery to the Brain for Treating Neurogenetic Diseases -- Chapter 5 Sleep Deprivation Induced Blood-Brain Barrier Breakdown and Brain Pathology. Neuroprotective Effects of Tio2-Nanowired Delivery of Cerebrolysin and Ondansetron -- Chapter 6 Glyco-Functionalised Biomaterials in Neuroregeneration -- Chapter 7 Targeting Nanoparticles to Brain: Impact of N-Methyl D-Aspartate Receptors.
520 3 _aThis book summarizes the latest research on drug and gene delivery to the central nervous system (CNS). The chapters address safety concerns regarding the nanotechnology that is needed to develop nanomedicine for clinical practice. Particular focus is given to new technologies that have emerged in recent years to deliver therapeutic materials, such as genes, drugs, and other agents using nanotechnologies of diverse origin. This is an ideal book for students, teachers, researchers, and clinicians interested in a deeper understanding of nanotechnological advances in therapeutic medicine. This book also: Broadens readers' understanding of viral vector gene delivery to the brain for treating neurogenetic diseases as well as targeted gene delivery into the brain using microbubble-facilitated focused ultrasound Covers in detail the latest developments in delivering therapeutic materials, such as siRNA delivery to the brain for treating neurological diseases, neuroprotective effects of gelatin nanoparticles in stroke, and nanowired drug delivery for brain diseases, heat stroke, and CNS injury Enriches understanding of new technologies for delivering therapeutic materials treating Alzheimer's Disease, including targeted nanodrug delivery through the blood-brain barrier and the superior neuroprotective effects of nanowired drug delivery in Alzheimer's Disease.
588 0 _aOnline resource; title from PDF title page (EBSCO, viewed June 15, 2017).
988 _aEBOOK, EBSPRINGER_2017D
650 7 _2embne
_9173033
_aMedicamentos
_xAdministración
700 1 _aMureșanu, Dafin,
_eeditor literario
700 1 _aSharma, Aruna,
_eeditor literario
700 1 _aSharma, H. S.
_q(Hari Shanker),
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-57696-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b02/2018
_dz
_e-
_zSI